Cell Cycle Regulation and Apoptotic Cell Death in Experimental Colon Carcinogenesis: Intervening with Cyclooxygenase-2 Inhibitors

REFERENCES

• Deshpande A, Sicinski P, and Hinds PW: Cyclins and cdks in development and cancer: a perspective. Oncogene 24, 2909–2915, 2005.
   PubMed Web of Science ®Google Scholar
• Nakayama KI and Nakayama K: Ubiquitin ligases: Cell-cycle control and cancer. Nat Rev Cancer 6, 369–381, 2006.
   PubMed Web of Science ®Google Scholar
• Sherr CJ and Roberts JM: Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18, 2699–2711, 2004.
   PubMed Web of Science ®Google Scholar
• Alenzi FQ: Links between apoptosis, proliferation and the cell cycle. Br J Biomed Sci 61, 99–102, 2004.
   PubMed Web of Science ®Google Scholar
• Tominaga O, Nita ME, Nagawa H, Fujii S, Tsuruo T, et al.: Expressions ofcell cycle regulators in human colorectal cancercell lines. Jpn J Cancer Res 88, 855–860, 1997.
   PubMedGoogle Scholar
• Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, and Pagano M: A nuclear protein essential for the Gl-to-S phase transition. Mol Cell Biol 15, 2612–2624, 1995.
   PubMed Web of Science ®Google Scholar
• Biliran HJr, Wang Y, Banerjee S, Xu H, Heng H, et al.: Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene expressing pancreatic tumor cell line. Clin Cancer Res 11, 6075–6086, 2005.
   PubMed Web of Science ®Google Scholar
• Donnellan R and Chetty R: Cyclin E in human cancers. FASEB J 13, 773–780, 1999.
   PubMed Web of Science ®Google Scholar
• Wu L and Levine AJ: Differential regulation of the p21/WAF-1 and mdm2 genes after high-dose UV irradiation:p53-dependent andp53-independent regulation of the mdm2 gene. Mol Med 3, 441–451, 1997.
   PubMed Web of Science ®Google Scholar
• Sionov RV and Haupt Y: The cellular response to p53: The decision between life and death. Oncogene 18, 6145–6157, 1999.
   PubMed Web of Science ®Google Scholar
• Colman MS, Afshari CA, and Barrett JC: Regulation of p53 stability and activity in response to genotoxic stress. Mutat Res 462, 179–188, 2000.
   PubMed Web of Science ®Google Scholar
• Bartek J and Lukas J: Pathways governing G1/S transition and their response to DNA damage. FEBS Lett 490, 117–122, 2001.
   PubMed Web of Science ®Google Scholar
• Taylor WR and Stark GR: Regulation of the G2/M transition by p53. Oncogene 20, 1803–1815, 2001.
   PubMed Web of Science ®Google Scholar
• Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342–348, 2001.
   PubMed Web of Science ®Google Scholar
• Matthews MB, Bernstein RM, Franza BR Jr, and Garrels JI: Identity of the proliferating cell nuclear antigen and cyclin. Nature 309, 374–376, 1984.
   PubMed Web of Science ®Google Scholar
• Bravo R, Rainer F, Blundell PA, and Macdonald-Bravo H: Cyclin/ PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326, 515–517, 1987.
   PubMed Web of Science ®Google Scholar
• Celis JE and Celis A: Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: Subdivision of S phase. Proc Natl Acad Sci USA 82, 3262–3266, 1985.
   PubMed Web of Science ®Google Scholar
• Williams CS, Smalley W, and DuBois RN: Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 100, 1325–1329, 1997.
   Google Scholar
• Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, et al.: NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 4, 2690–2698, 1999.
   Google Scholar
• Saini MK, Kaur J, Sharma P, and Sanyal SN: Chemopreventive response of diclofenac, a non-steroidal anti-inflammatory drug in experimental carcinogenesis. Nutr Hosp 24, 717–723, 2009.
   PubMed Web of Science ®Google Scholar
• Saini MK, Vaiphei K, and Sanyal SN: Chemoprevention of DMH induced rat colon carcinoma initiation by combination administration of piroxicam and C-phycocyanin. Mol Cell Biochem 361, 217–228, 2012.
   PubMed Web of Science ®Google Scholar
• LaMont JT and O'Gorman TA: Experimental colon cancer. Gastroenterology 75, 1157–1169, 1978.
   PubMed Web of Science ®Google Scholar
• Rosenberg DW, Giardina CS, and Tanaka T: Mouse models for the study of colon carcinogenesis. Carcinogenesis 30, 183–196, 2009.
   PubMed Web of Science ®Google Scholar
• Fiala ES and Stathopoulos C: Metabolism of methylazoxymethanol acetate in the F344 rat and strain-2 guinea pig and its inhibition by pyrazole and disulfiram. J Cancer Res Clin Oncol 108, 129–134, 1984.
   PubMed Web of Science ®Google Scholar
• Fiala ES, Bobotas G, Kulakis C, Wattenberg LW, and Weisburger JH: Effects of disulfiram and related compounds on the metabolism in vivo of the colon carcinogen, 1,2-dimethylhydrazine. Biochem Pharmacol 26, 1763–1768, 1977.
   PubMed Web of Science ®Google Scholar
• Grab DJ and Zedeck MS: Organ-specific effects of the carcinogen methylazoxymethanol related to metabolism by nicotinamide adenine dinucleotide-dependent dehydrogenases. Cancer Res 37, 4182–4189, 1977.
   PubMed Web of Science ®Google Scholar
• Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 7, 248–254, 1976.
   Web of Science ®Google Scholar
• Vaish V and Sanyal SN: Role of Sulindac and Celecoxib in chemoprevention of colorectal cancer via intrinsic pathway of apoptosis: Exploring NHE-1, intracellular calcium homeostasis and Calpain 9. Biomed Pharmacother 66, 116–130, 2012.
   PubMed Web of Science ®Google Scholar
• Simon P: Q-Gene: processing quantitative real-time RT-PCR data. Bioinformatics 19, 1439–1440, 2003.
   PubMed Web of Science ®Google Scholar
• Saini MK, Vaiphei K, and Sanyal SN: Piroxicam and C-phycocyanin mediated apoptosis in 1,2-dimethylhydrazine dihydrochloride induced colon carcinogenesis: Exploring the mitochondrial pathway. Nutr Cancer 3, 409–418, 2012.
   Web of Science ®Google Scholar
• Mouille B, Robert V, and Blacheir F: Adaptative increase of ornithine production and decrease of ammonia metabolism in rat colonocytes after hyperproteic diet ingestion. Am J Physiol Gastrointest Liver Physiol 287, G344–G351, 2004.
   PubMed Web of Science ®Google Scholar
• Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, and Lipton SA: Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with NMDA or nitric oxide/superoxide in cortical cultures. Proc Natl Acad Sci USA 92, 7162–7166, 1995.
   PubMed Web of Science ®Google Scholar
• Piccagli L, Fabbri E, Borgatti M, Bezzerri V, Mancini I, et al.: Docking of molecules identified in bioactive medicinal plants extracts into the p50 NF-kappa B transcription factor: correlation with inhibition of NF-kappa B/DNA interactions and inhibitory effects on IL-8 gene expression. BMC Struct Biol 8, 38, 2008.
   PubMed Web of Science ®Google Scholar
• Freisner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, et al.: Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49, 6177–6196, 2006.
   PubMed Web of Science ®Google Scholar
• Romay C, Gonzalez R, Ledon N, Remirez D, Rimbau V: Phycocyanin: A biliprotein with antioxidant, anti-inflammatory and neuroprotective effects. Current Protein and Peptide Science 4, 207–216, 2003.
   PubMed Web of Science ®Google Scholar
• Shih CM, Cheng SN, Wong CS, Kuo YL, and Chou TC: Antiinflammatory and antihyperalgesic activity of C-phycocyanin. Anesth Analg 108, 1303–1310, 2009. doi:10.1213/ane.0b013e318193e919.
   PubMed Web of Science ®Google Scholar
• Van Diest PJ, Michalides RJ, Jannink L, Van der Valk P, Peterse HL, et al.: Cyclin D1 overexpression in breast cancer, Correlations and prognostic value. Am J Pathol 150, 705–711, 1997.
   PubMed Web of Science ®Google Scholar
• Aaltomaa S, Karja V, Lipponen P, Isotalo T, Kankkunen JP, et al.: Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy. Anticancer Res 26, 4873–4878, 2006.
   PubMed Web of Science ®Google Scholar
• Johnson DG and Walker CL: Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 39, 295–312, 1999.
   PubMed Web of Science ®Google Scholar
• Lloret S, Torrent M, and Moreno JJ: Proliferation-dependent changes in arachidonic acid mobilization from phospholipids of 3T6 fibroblasts. Pflugers Archv Eur J Physiol 432, 655–662, 1996.
   PubMed Web of Science ®Google Scholar
• Nieves D and Moreno JJ: Hydroxyeicosatetraenoic acids released through the cytochrome P-450 pathway regulate 3T6 fibroblast growth. J Lipid Res 47, 2681–2689, 2006.
   PubMed Web of Science ®Google Scholar
• Na HK and Surh YJ: Peroxisome proliferator-activated receptor gamma (PPAR gamma) ligands as bifunctional regulators of cell proliferation. Biochem Pharmacol 66, 1381–1391, 2003.
   PubMed Web of Science ®Google Scholar
• Rizzo G and Fiorucci S: PPARs and other nuclear receptors in inflammation. Curr Opin Pharmacol 6, 421–427, 2006,
   PubMed Web of Science ®Google Scholar
• Vermeulen K, Van Bockstaele DR, and Berneman ZN: The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36, 131–149, 2003.
   PubMed Web of Science ®Google Scholar
• Shiff SJ, Qiao L, Tsai LL, and Rigas B: Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 96, 491–503, 1995.
   PubMed Web of Science ®Google Scholar
• Grosch S, Maier TJ, Schiffmann S, and Geisslinger G: Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 98, 736–747, 2006.
   PubMed Web of Science ®Google Scholar
• Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, et al.: Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523–527, 1997.
   PubMed Web of Science ®Google Scholar
• Rayet B and Gelinas C: Aberrant rel/nfkb genes and activity in human cancer. Oncogene18, 6938–6947, 1999.
   PubMed Web of Science ®Google Scholar
• Pierce JW, Read MA, Ding H, Luscinskas FW, and Collins T: Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression and neutrophil transmigration. J Immunol 156, 3961–3969, 1996.
   PubMed Web of Science ®Google Scholar
• Bharti AC and Aggarwal BB: Chemopreventive agents induce suppression of nuclear factor-κB leading to chemosensitization. Ann NY Acad Sci 973, 392–395, 2002.
   PubMed Web of Science ®Google Scholar